Dan Salvo, Author at Forge Biologics

PRESS: Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean April 6, 2021 by Dan Salvo in Biologics News
Hearthside Chat Video Series March 26, 2021 by Dan Salvo in Biologics News
PRESS: FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease February 16, 2021 by Dan Salvo in Biologics News&Press Releases
PRESS: United Leukodystrophy Foundation January 27, 2021 by Dan Salvo in Biologics News
VIDEO: Manufacturing Capabilities January 25, 2021 by Dan Salvo in Biologics News
“Building Better” Blog: Forge Biologics Spotlight January 22, 2021 by Dan Salvo in Biologics News
RESKUE Trial for Patients with Krabbe Disease January 21, 2021 by Dan Salvo in Biologics News
Announcing: Blaze Vector™ Production January 12, 2021 by Dan Salvo in Biologics News
PRESS: FDA Clearance of Investigational New Drug for Patients with Krabbe Disease January 4, 2021 by Dan Salvo in Biologics News
Our Gene Therapy Players: The Starting Lineup December 23, 2020 by Dan Salvo in Biologics News